Ross D. Bathgate
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Identification and functional characterisation of the relaxin-like gonad-stimulating peptide receptor in sea cucumbers.
Journal: General and comparative endocrinology
Published: April 26, 2026
Understanding insulin-like peptide 5 (INSL5) and relaxin family peptide receptor 4 (RXFP4): structure, signalling, and function.
Journal: RSC chemical biology
Published: March 18, 2026
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.
Journal: British journal of pharmacology
Published: December 29, 2025
From Structure to Function: Development of Relaxin-3 Analogs and their Role in RXFP3 Signaling.
Journal: Chembiochem : a European journal of chemical biology
Published: September 01, 2025
Design and Synthesis of a Structurally Stabilized B‑Chain Antagonist Targeting Relaxin Family Peptide Receptor 3 (RXFP3).
Journal: ACS medicinal chemistry letters
Published: August 13, 2025
In vivo induction of crown-of-thorns starfish (Acanthaster spp.) spawning using a synthetic relaxin-like gonad-stimulating peptide.
Journal: General and comparative endocrinology
Published: June 03, 2025
Engineering of Novel Analogues That Are More Receptor-Selective and Potent than the Native Hormone, Insulin-like Peptide 5 (INSL5).
Journal: Journal of medicinal chemistry
Published: November 21, 2024
Biallelic RXFP2 variants lead to congenital bilateral cryptorchidism and male infertility, supporting a role of RXFP2 in spermatogenesis.
Journal: Human reproduction (Oxford, England)
Published: March 12, 2024
Total Chemical Synthesis of Aggregation-Prone Disulfide-Rich Starfish Peptides.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: March 06, 2024
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology.
Journal: Biochemical pharmacology
Published: February 16, 2024
Identification of a Novel Subtype-Selective α1B-Adrenoceptor Antagonist.
Journal: ACS chemical neuroscience
Published: January 18, 2024
Last Updated: 09/26/2026